Exacerbation of migraine attacks during treatment with the selective serotonin reuptake inhibitor sertraline. A case report. [electronic resource]
- Pharmacopsychiatry Nov 2005
- 327-8 p. digital
Publication Type: Case Reports; Letter
0176-3679
10.1055/s-2005-916190 doi
Adrenergic beta-Antagonists--therapeutic use Antimanic Agents--therapeutic use Depressive Disorder, Major--complications Female Humans Lithium--therapeutic use Metoprolol--therapeutic use Middle Aged Migraine Disorders--chemically induced Serotonin Receptor Agonists--therapeutic use Selective Serotonin Reuptake Inhibitors--adverse effects Sertraline--adverse effects